Pnc Financial Services Group, Inc. Ligand Pharmaceuticals Inc Transaction History
Pnc Financial Services Group, Inc.
- $190 Billion
- Q1 2025
A detailed history of Pnc Financial Services Group, Inc. transactions in Ligand Pharmaceuticals Inc stock. As of the latest transaction made, Pnc Financial Services Group, Inc. holds 2,030 shares of LGND stock, worth $233,470. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,030
Previous 2,101
3.38%
Holding current value
$233,470
Previous $225,000
5.33%
% of portfolio
0.0%
Previous 0.0%
Shares
31 transactions
Others Institutions Holding LGND
# of Institutions
280Shares Held
19MCall Options Held
9.5KPut Options Held
8.1K-
Black Rock Inc. New York, NY2.87MShares$330 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.06MShares$236 Million0.0% of portfolio
-
Janus Henderson Group PLC London, X01.03MShares$118 Million0.06% of portfolio
-
Macquarie Group LTD Australia, C3906KShares$104 Million0.12% of portfolio
-
Dimensional Fund Advisors LP Austin, TX745KShares$85.7 Million0.02% of portfolio
About LIGAND PHARMACEUTICALS INC
- Ticker LGND
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 16,882,800
- Market Cap $1.94B
- Description
- Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...